AstraZeneca's Earnings Beat Shows Momentum, Pipeline Revenue Goals Questioned

AstraZeneca reported earnings that surpassed expectations, indicating strong momentum, but questions remain about the ability of its pipeline to deliver an ambitious $80 billion in revenue.